Scope Health: Optase Dry Eye Intense Drops (glycerin 0.2%)
Recall Summary Scope Health is recalling Optase Dry Eye Intense Drops (Glycerin 0.2%) in 0.33 fl oz bottles nationwide because the company cannot confirm the product is sterile. The product was distributed across all U.S. states and the District of Columbia. This is a Class II recall, meaning use of the product could cause temporary or reversible health effects.
- Recalling firm
- SCOPE HEALTH
- Product
- Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.
- Reason
- Lack of Assurance of Sterility
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-04-20
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the United States
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/da20bb92-f1b7-4801-99ca-059fb1bf61c9